US 8945559
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted A61KA61K39/39591A61K47/183
Quick answer
US patent 8945559 (Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K39/39591, A61K47/183, A61K9/0019, A61P